Ken d'Entremont
Chief Executive Officer
Replay available
Medexus Pharmaceuticals Inc. (MDP) Q4 2026 Earnings Call
Medexus Pharmaceuticals Inc. (TSX: MDP) Q4 2026 earnings conference call, held 2026-06-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Scott Henry
Analyst, Alliance Global Partners
Michael Freeman
Analyst, Raymond James
Brendon Buschman
Chief Financial Officer
David Martin
Analyst, Bloom Burton
Victoria Rutherford
Investor Relations
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Medexus Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.051 -- 00:00:05.074 Greetings. Welcome to the Medexus Pharmaceuticals fiscal fourth quarter 00:00:05.074 -- 00:00:06.635 in year 00:00:06.635 -- 00:00:12.519 end 2026 conference call. At this time, all participants are in a listen-only mode. 00:00:12.519 -- 00:00:16.581 A question and answer session will follow the formal presentation. 00:00:16.581 -- 00:00:21.104 If anyone should require operator assistance during the conference, please press star 00:00:21.104 -- 00:00:26.327 zero on your telephone keypad. Please note this conference is being recorded. 00:00:26.327 -- 00:00:30.575 I will now like to turn the conference over to your host, Victoria Rutherford, Investor 00:00:30.575 -- 00:00:32.956 Relations of Medexus. You may begin. 00:00:32.956 -- 00:00:34.956 Thank 00:00:35.338 -- 00:00:40.420 you and good morning everyone. Welcome to the Medexus Pharmaceuticals 00:00:40.420 -- 00:00:45.183 fiscal fourth quarter and year-end 2026 earnings call. 00:00:45.183 -- 00:00:49.405 On the call this morning are Ken d'Entremont, Chief Executive Officer, and Brendon Buschman, 00:00:49.405 -- 00:00:53.587 Chief Financial Officer. If you have any questions after the conference call or would 00:00:53.587 -- 00:00:59.689 like further information about the company, please contact Adelaide Capital at 480-625- 00:00:59.773 -- 00:01:05.276 I would like to remind everyone that this discussion will include forward-looking 00:01:05.276 -- 00:01:10.698 information as defined in Canadian securities laws that is based on certain assumptions 00:01:10.698 -- 00:01:15.841 that Medexis believes to be reasonable in the circumstances but is subject to risks 00:01:15.841 -- 00:01:20.924 and uncertainties. Actual results may differ materially from historical results or 00:01:20.924 ...